Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07081828

The Asensus Paediatric Robotic Registry

An open-label, observational, paediatric registry trial in which participating centers enroll subjects who had or will have a laparoscopically-assisted surgery using the Senhance Surgical System.

Recruiting

Interested in participating?

Request Info

Key information

Age range

Up to 17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dr. von Hauner Children's Hospital Clinic of the University of Munich

München, Germany

Location status: Recruiting

Location contact

Jan Gödeke, MD, MBA

CONTACT

[email protected]

+49 89 4400 53101

About this study

This is a prospective and retrospective, multi-center, observational registry study evaluating the use of the Senhance Surgical System in paediatric patients undergoing laparoscopically-assisted surgery. The trial is open-label and designed to collect both historical and prospective data from participating centers. Paediatric subjects who have undergone or will undergo procedures with the Senhance Surgical System will be enrolled. The primary purpose for this study is to assess safety outcomes. Secondary endpoints include length of hospital stay, procedural information, and patient-reported outcomes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • < 18 years of age
  • Body weight > 10 kg
  • Indication for a potential robot-assisted operation
  • Expected survival of > 3 months

Exclusion criteria

  • Subjects requiring surgery on the heart or greater vessels.
  • Subjects for whom a laparoscopic approach and endoscopic approach in the thoracic area is not appropriate.
  • Anaesthetic contraindications, children with pacemakers or other implants for which electrosurgery must be avoided, children with cancer, parents who prefer to proceed with classical or manual laparoscopic surgery.
  • Subjects pregnant over the second trimester of pregnancy.
  • Parents or children with insufficient understanding of the site's local language (e.g. Dutch, German) or English language.
  • Presence of any relevant severe condition or clinically relevant abnormal laboratory parameters due to which an endoscopic or laparoscopic surgical technique is contraindicated.
  • Subjects who would require an intervention to the upper mediastinum or to the upper pleural cavity regions as referred in the Senhance Surgical System User Manual (UM-001-00035_CE).

Treatment and study plan

surgery

Device

Patients who undergo surgery utilising the Senhance Surgical System.

Primary outcomes

  1. Adverse Event

    Time frame: Index surgery to 30 days postoperative

    Rate of Adverse Event (Clavien >3)

  2. Procedure-related severe adverse event

    Time frame: Index surgery to 30 days post-operative

    Percent of procedurally related SAE after adjudication

Secondary outcomes

  1. Length of Stay

    Time frame: From day of index procedure to hospital discharge, up to 2 weeks

    Total duration (in days) of hospitalization related to the index surgical procedure

  2. Conversion to unplanned open surgery

    Time frame: Intraoperative (during index surgical procedure)

    Rate of unplanned conversions from laparoscopic to open surgery.

  3. COMFORT-B scale for assessing pain in pediatric patients aged 0 to less than 2 years of age

    Time frame: Day after index surgery to day of discharge from hospital for index surgery, up to 2 weeks.

    The COMFORT-B Score is a validated behavioral assessment tool designed to evaluate the level of sedation, pain, and distress in pediatric patients. The COMFORT-B scale will be used to assess pain levels in children aged 0 to less than 2 years of age. The COMFORT-B scale includes six behavioral dimensions: Alertness, Calmness/Agitation, Respiratory Response (only in mechanically ventilated children), Crying (only in spontaneously breathing children), Physical Movement, Muscle Tone, and Facial Tension. Each dimension is scored on a scale from 1 to 5, yielding a total score range of 6 to 30. Higher scores indicate greater distress or discomfort.

  4. Face, Legs, Activity, Cry, Consolability (FLACC) behavioral pain scale for children aged 2 years to less than 7 years of age.

    Time frame: Day after index surgery to day of discharge from hospital for index surgery, up to 2 weeks.

    The FLACC scale assesses pain by observing five categories of behaviors and assigning a score of 0-2 to each category, resulting in a total score of 0-10, where a score of 10 indicates a higher level of pain.

    The following five behavioral categories are assessed: Facial expression, leg movement, Activity level, Crying, and Consolability.

    The FLACC scale will be utilized to assess pain in children aged 2 to less than 7 years of age.

  5. Numerical Rating Scale (NRS) for assessing pain in patients aged 7 years to less than 18 years of age.

    Time frame: Day after index surgery to day of discharge from hospital for index surgery, up to 2 weeks.

    Pain will be assessed using a numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain). The NRS scale will be used for patients aged 7 years to less than 18 years of age.

Study contacts

Contact information is provided by the study sponsor or research team.

Monica Marini

CONTACT

[email protected]

Stephanie Smith, PhD

CONTACT

[email protected]

608-957-4850

Sponsors and collaborators

Lead sponsor

Asensus Surgical

Industry

Collaborators

  • RQM+

Registry information

Official study title

The Asensus Paediatric Registry of Robotic-Assisted Endoscopic Procedures in Urology, Gynaecology, and General Surgery

Acronym: miniTRUST

Important dates

Study start
2025
Primary completion
2035
Study completion
2035
First posted
Jul 23, 2025
Registry last updated
Jul 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.